Controlled release dosage forms
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsE. Lerner, Vered Rosenberger, Ofer Aqua, Moshe Flashner-Barak
Life of this patent
Estimating the term…
Abstract
A zero-order release pharmaceutical dosage form for oral administration to a patient comprising a core tablet sheathed in an annular body of compressed powder or granular material is provided. A preferred embodiment of the zero-order release pharmaceutical dosage form is a solid pharmaceutical dosage form which reduces contact of the active ingredient in solid form with the mucosa lining the gastrointestinal tract, which is particularly advantageous for delivering an ulcerative drug. A process for making the zero-order release pharmaceutical dosage form are also provided.
Claims11
A pharmaceutical dosage form for oral administration to a patient comprising a core tablet containing an active ingredient sheathed in an annular body of compressed powder or granular material, that releases about 90% or more of the active ingredient from the core tablet within about 30 minutes.
Dependencies are inferred from the claim text.